Related Experiment Videos
Dopamine and inhibition of prolactin and growth-hormone secretion
Lancet (London, England)
|April 24, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of alpha- and Beta-adrenergic agonists and antagonists on growth hormone secretion in man.
Journal of neuroendocrinology·2009
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry.
Journal of endocrinological investigation·2006
Diagnosis of adult growth hormone deficiency: still a matter of debate.
Journal of endocrinological investigation·2006
[Growth hormone and lipids].
Minerva gastroenterologica e dietologica·2006
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease.
Journal of endocrinological investigation·2005
Developing roadmaps for advancing practice, research, and policy in the arts and health.
Lancet (London, England)·2026
Precision prevention and early detection: framework for a new clinical cancer control pathway.
Lancet (London, England)·2026
Combination Therapy of Salbutamol and Spirulina: A Novel Dual-Action Approach for Asthma Management.
Mini reviews in medicinal chemistry·2026
Psychiatric Association of Türkiye Mood Disorders Section Depression Treatment Guideline - III: Treatment Approach for Depression Subtypes and Special Groups, Psychotherapies, and Psychosocial Interventions.
Turk psikiyatri dergisi = Turkish journal of psychiatry·2026
The emerging role of PDE4 inhibitors for the treatment of pulmonary fibrosis.
Expert review of clinical pharmacology·2026
Common Pain Medications: Indications, Efficacy, Dosing, Formulations, Mechanisms of Action, and Contraindications.
Psychopharmacology bulletin·2026
Complementary roles of Smad6 and Smad7 in BMP-15-mediated steroidogenic regulation in granulosa cells.
Biochemical and biophysical research communications·2026
Oral PCSK9 inhibitors: closing the gap between potency and practicality.
Current opinion in lipidology·2026